VICTOR L. CRAWFORD

CIK 1449780 · CEO, Pharmaceutical Segment · last filed 2025-04-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.72M

Companies

4

Total Filings

44

Lifetime Open-Market Net

-$687.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HSY Director 4,885 $181.66 $887.5K $0 22 2025-04-03
CAH CEO, Pharmaceutical Segment 105,699 $223.85 $23.66M $0 10 2022-08-17
PLAY Director 13,409 $12.93 $173.4K $0 5 2020-04-28
PEPSI BOTTLING GROUP INC (PBG) Delisted SVP, Glbl Ops&Sys Transformatn 0 -$687.9K 7 2010-02-26

Recent Filings · Page 2 of 5

44 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-04-04 HSY Grant (A) +167 $0 EDGAR
2023-01-04 HSY Grant (A) +182 $0 EDGAR
2022-10-03 HSY Grant (A) +178 $0 EDGAR
2022-08-17 CAH Mixed −12,802 -$2.08M EDGAR
2022-08-11 CAH Grant (A) +36,536 $0 EDGAR
2022-07-05 HSY Grant (A) +183 $0 EDGAR
2022-04-04 HSY Grant (A) +185 $0 EDGAR
2022-01-03 HSY Grant (A) +208 $0 EDGAR
2021-11-16 CAH Tax (F) −4,391 -$225.9K EDGAR
2021-10-01 HSY Grant (A) +235 $0 EDGAR
Showing 1120 of 44
Page 2 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.